KPWS
LUCD icon

Kestra Private Wealth Services’s Lucid Diagnostics LUCD Stock Holding History

Kestra Private Wealth Services’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Buy
14,000
+900
+7% +$970 ﹤0.01% 1803
2026
Q1 		$15.1K Buy
+13,100
New +$16.7K ﹤0.01% 1746

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Kestra Private Wealth Services's LUCD Position: Q2 2026 in Review

Kestra Private Wealth Services increased its Lucid Diagnostics (LUCD) stake by 6.9% in Q2 2026, buying an estimated $970 and bringing the position to 14,000 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

Kestra Private Wealth Services first reported a position in LUCD in Q1 2026 and has held it in 2 quarters since. The position peaked at $15.1K in Q1 2026. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Kestra Private Wealth Services held 14,000 shares of Lucid Diagnostics worth $15K as of Q2 2026.
  • Kestra Private Wealth Services bought 900 Lucid Diagnostics shares in Q2 2026, an estimated $970.
  • Lucid Diagnostics made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1803 holding.
  • Kestra Private Wealth Services first reported a position in Lucid Diagnostics in Q1 2026 and has held it in 2 quarters since.
  • Kestra Private Wealth Services's Lucid Diagnostics position peaked at $15.1K in Q1 2026.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.